Cyclica built a proprietary early-stage drug discovery platform that provides statistical rankings of the on- and off-target effects of a small molecule drug in the human body. Cyclica was acquired by Recursion in Q2 2023.

No comment yet, add your voice below!

Add a Comment

Your email address will not be published. Required fields are marked *